Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06042127

POEM-F for Achalasia International Study

Led by Chinese University of Hong Kong · Updated on 2024-12-03

81

Participants Needed

7

Research Sites

152 weeks

Total Duration

On this page

Sponsors

C

Chinese University of Hong Kong

Lead Sponsor

D

Deenanath Mangeshkar Hospital and Research Centre

Collaborating Sponsor

AI-Summary

What this Trial Is About

Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in up to 50-60% of patients. In order to reduce the risk of GERD, endoscopic fundoplication has been developed as a novel procedure mimicking surgical anterior partial fundoplication that can be performed in the same session as POEM (POEM-F). Case series of POEM-F in patients with achalasia reported encouraging outcomes of low GERD rate of \~12% at 1 year. Prospective comparative data between POEM-F and conventional POEM on post-procedure GERD is current lacking. The investigators therefore designed an international multicenter prospective randomized study to investigate the efficacy of POEM-F. The investigators postulate that POEM-F could reduce the incidence of post-procedure GERD when compared with conventional POEM. This is an international multicenter randomized controlled trial conducted between high volume expert centers from Hong Kong SAR, China, India and United States of America. Adult patients with manometry confirmed achalasia would be randomised to undergo POEM-F or POEM. The procedure would be performed by experts with vast experience in POEM. The primary outcome is the incidence of post-procedure GERD at 1 year, defined by the updated Lyon consensus. Secondary outcomes include technical and clinical success rates, adverse events, post-POEM endoscopic and manometry findings as well as patients' symptom scores. Sample size calculation Based on existing pilot comparative data on POEM-F and POEM, it is estimated that 84 patients would be required to demonstrate a difference in post-procedure GERD of 47.6% to 18.2%, with 80% power and false positive rate of 0.05, accounting for 10% loss to follow-up. Purpose and potential The current study proposal could demonstrate the superiority of POEM-F over POEM in reducing post-procedural GERD. It would also demonstrate the safety and reproducibility of the technique in expert centers across the globe. It could potentially replace conventional POEM as the preferred minimally invasive endoscopic treatment for achalasia.

CONDITIONS

Official Title

POEM-F for Achalasia International Study

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged 18 to 65 years with symptomatic achalasia type I or II
  • Able to understand and comply with study tasks, including filling out symptom questionnaires and providing informed consent
  • Patients with achalasia type I, II, or III who are either treatment-na�efve or have failed prior balloon or pneumatic dilation treatment
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide consent
  • Previous esophageal or gastric surgery
  • Prior achalasia treatments including Heller myotomy or POEM
  • Sigmoid achalasia or significant esophageal dilation greater than 6 cm in the lower esophagus
  • Damaged mucosal lining in the lower esophagus such as ulcers or fibrotic scars
  • Large hiatal hernias with axial length over 2 cm and Hill grade above 2
  • Significant heart or lung diseases limiting general anesthesia, including ASA grade III or higher
  • Obesity with body mass index of 30 or higher
  • Pregnant, planning pregnancy, or breastfeeding women
  • Uncorrectable blood clotting problems with INR above 1.5 or platelet count below 50,000 per microliter

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21287

Not Yet Recruiting

2

Nanfang Hospital, Southern Medical University

Guangzhou, China

Not Yet Recruiting

3

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Actively Recruiting

4

Post Graduate Institute of Medical Education and Research

Chandigarh, India

Not Yet Recruiting

5

Asian Institute of Gastroenterology

Hyderabad, India

Not Yet Recruiting

6

Baldota Institute of Digestive Sciences

Mumbai, India

Not Yet Recruiting

7

Deenanath Mangeshkar Hospital & Research Center

Pune, India

Not Yet Recruiting

Loading map...

Research Team

H

Hon Chi Yip, FRCSEd

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here